Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)

NCT03246529

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Loyola University Medical Center Chicago, Illinois, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

NCT04812925

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010116 Bentonville, Arkansas, United States
  • Investigator site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010062 Fort Wayne, Indiana, United States
  • Investigator site US0010042 Iowa City, Iowa, United States
View all 83 locations
View Trial Details
Active, Not Recruiting

Gene Transfer for Sickle Cell Disease

NCT03282656

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • UCLA - Mattel Children's Hospital Los Angeles, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

NCT04468984

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Ironwood Cancer & Res Ctr /ID# 222162 Chandler, Arizona, United States
  • Highlands Oncology Group, PA /ID# 221826 Springdale, Arkansas, United States
  • City of Hope /ID# 218996 Duarte, California, United States
  • Providence - St. Jude Medical Center /ID# 271382 Fullerton, California, United States
View all 229 locations
View Trial Details
Active, Not Recruiting

Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation

NCT04203316

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center Denver, Colorado, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT06291220

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • City of Hope /ID# 253904 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 267158 Irvine, California, United States
  • Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana /ID# 264622 Billings, Montana, United States
  • Atrium Health /ID# 265136 Charlotte, North Carolina, United States
View all 21 locations
View Trial Details

Related conditions